Aratana Therapeutics Inc. | Key People and Executives
Wendy L. Yarno
Non-Executive Chairman
Steven St. Peter
President, Chief Executive Officer & Director
Lowell W. Robinson
Director
Craig A. Barbarosh
Director
Irvine O. Hockaday
Independent Director
Robert P. Roche
Independent Director
David L. Brinkley
Independent Director
Merilee Raines
Independent Director
Laura A. Brege
Independent Director
John W. Vander Vort
Independent Director
Wendy L. Yarno
Non-Executive Chairman
Steven St. Peter
President, Chief Executive Officer & Director
Brent A. Standridge
Chief Operating Officer
Craig A. Tooman
Chief Financial Officer & Treasurer
Jeffrey Michael Jones
Vice President-Business Development
Laura Simon Treml
Director-Drug Development
Ernst Heinen
Chief Development Officer
Lowell W. Robinson
Director
Craig A. Barbarosh
Director
John Paolucci
Marketing Director
Rachel Reiff
Head-Corporate Communications
Debbie Walls
Vice President-Human Resources
John C. Ayres
Secretary & General Counsel
Irvine O. Hockaday
Independent Director
Robert P. Roche
Independent Director
David L. Brinkley
Independent Director
Merilee Raines
Independent Director
Laura A. Brege
Independent Director
John W. Vander Vort
Independent Director
| Address |
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
|
|
Employees
|
- |
| Website |
http://www.aratana.com |
| Updated |
07/08/2019 |
| Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. |
